We have observed
8 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 27, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Increasing the bioavailability of hydroxycinnamic acids
A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
1-O-alkyl-2-acylglycerophosphocholine (PC-O) 40:1 as biomarker for healthy ageing
9-oxo-octadecadienoic acid (9-oxo-HODE)as as biomarker for healthy ageing
Hydroxy-sphingomyelin 22:1 as biomarker for healthy ageing
p-Cresol sulphate as biomarker for healthy ageing
Phenylacetylglutamine as biomarker for healthy ageing
Anti-obesity agent and anti-obesity food